Attached files

file filename
EX-3.3 - EX-3.3 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex33_68.htm
EX-32.2 - EX-32.2 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex322_8.htm
EX-31.2 - EX-31.2 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex312_6.htm
EX-31.1 - EX-31.1 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex311_9.htm
EX-10.2 - EX-10.2 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex102_245.htm
EX-10.1 - EX-10.1 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex101_46.htm
EX-3.2 - EX-3.2 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex32_67.htm
EX-3.1 - EX-3.1 - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-ex31_66.htm
10-Q - 10-Q - HELIUS MEDICAL TECHNOLOGIES, INC.hsdt-10q_20180630.htm

 

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

HELIUS MEDICAL TECHNOLOGIES, INC.

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2018

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I am the Chief Executive Officer of Helius Medical Technologies, Inc., a Wyoming corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended June 30, 2018 and filed with the Securities and Exchange Commission (“Form 10-Q”).

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 9, 2018

 

/s/ Phillippe Deschamps

 

 

Phillippe Deschamps

 

 

Chief Executive Officer and Director

 

 

(Principal Executive Officer)